云南“药王”为两个90后女儿分股份！市值1.57亿元

Core Viewpoint - The announcement from Yixin Tang Pharmaceutical Group indicates that the controlling shareholder, Ruan Hongxian, plans to transfer up to 5.856 million shares (1% of total share capital) to each of his daughters, Ruan Shengxiang and Ruan Aixiang, through block trading, which is part of family asset planning and will not affect the company's control or governance structure [1][6][4]. Group 1 - Ruan Hongxian currently holds 31.74% of Yixin Tang's shares, and the total market value of the company is approximately 7.9 billion yuan, making the transferred shares worth about 78 million yuan [4][6]. - The share transfer is characterized as an internal family transfer, and Ruan Hongxian will sign a "concerted action agreement" with his daughters post-transfer [1][4]. - Yixin Tang was founded in 1981 and has grown to operate 8,990 retail pharmacy stores across ten provinces and cities in China, becoming a publicly listed company in 2014 [6][8]. Group 2 - Ruan Hongxian and Liu Qiong co-founded the predecessor of Yixin Tang in 1987, and they were recognized as prominent figures in the pharmaceutical industry in Yunnan [8][9]. - Following their divorce in 2017, Ruan Hongxian and Liu Qiong divided their shares in Yixin Tang, with Ruan holding 33.75% and Liu holding 18.37% [8][9]. - Ruan Shengxiang and Ruan Aixiang, both in their 20s, are involved in the family business, with Ruan Shengxiang serving as vice chairman of Shengai Traditional Chinese Medicine Group and Ruan Aixiang appointed as vice president of Yixin Tang [13][16].